MicroRNAs: Emerging players in the pathogenesis of vitiligo

Vitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differ...

Full description

Bibliographic Details
Main Authors: Xin Yu, Yuli Cui, Xueqing Zhu, Hongjun Xu, Linfeng Li, Guangcheng Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/full
_version_ 1818023038176722944
author Xin Yu
Yuli Cui
Xueqing Zhu
Hongjun Xu
Linfeng Li
Guangcheng Gao
author_facet Xin Yu
Yuli Cui
Xueqing Zhu
Hongjun Xu
Linfeng Li
Guangcheng Gao
author_sort Xin Yu
collection DOAJ
description Vitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differentially expressed in skin lesions and peripheral blood mononuclear cells of patients with vitiligo. In particular, miRNAs are significantly correlated with the development and progression of vitiligo. The abundance of some miRNAs in serum was also correlated with the vitiligo lesion severity, indicating that miRNAs might serve as prognostic biomarkers. Importantly, the direct involvement of miRNAs in the pathogenesis of vitiligo has been demonstrated. For example, increased expression of miR-25 contributes to vitiligo through promoting the dysfunction and oxidative stress-induced destruction of melanocytes. However, there are limited studies on the function and mechanism of deregulated miRNAs in vitiligo. Further studies are required to establish clinical applications of miRNAs for vitiligo. More in-depth investigations of miRNAs are needed for the understanding of the pathogenesis of vitiligo and the development of novel therapeutic targets. This present review summarizes the current literature on the deregulation and pathogenic roles of miRNAs in vitiligo. We also highlight the potential clinical applications of miRNAs in patients with vitiligo.
first_indexed 2024-12-10T03:37:58Z
format Article
id doaj.art-e3d88e02653f4c9bb0af42977bee01ca
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-10T03:37:58Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-e3d88e02653f4c9bb0af42977bee01ca2022-12-22T02:03:40ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-09-011010.3389/fcell.2022.964982964982MicroRNAs: Emerging players in the pathogenesis of vitiligoXin YuYuli CuiXueqing ZhuHongjun XuLinfeng LiGuangcheng GaoVitiligo is an autoimmune skin disease characterized by presence of pale patchy areas of depigmentation. MicroRNAs (miRNAs) are important regulators of gene expression and play significant roles in diverse biological and pathological processes. Accumulating evidence has shown that miRNAs were differentially expressed in skin lesions and peripheral blood mononuclear cells of patients with vitiligo. In particular, miRNAs are significantly correlated with the development and progression of vitiligo. The abundance of some miRNAs in serum was also correlated with the vitiligo lesion severity, indicating that miRNAs might serve as prognostic biomarkers. Importantly, the direct involvement of miRNAs in the pathogenesis of vitiligo has been demonstrated. For example, increased expression of miR-25 contributes to vitiligo through promoting the dysfunction and oxidative stress-induced destruction of melanocytes. However, there are limited studies on the function and mechanism of deregulated miRNAs in vitiligo. Further studies are required to establish clinical applications of miRNAs for vitiligo. More in-depth investigations of miRNAs are needed for the understanding of the pathogenesis of vitiligo and the development of novel therapeutic targets. This present review summarizes the current literature on the deregulation and pathogenic roles of miRNAs in vitiligo. We also highlight the potential clinical applications of miRNAs in patients with vitiligo.https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/fullMicroRNAsvitiligopathogenesismiRNAMiR-25
spellingShingle Xin Yu
Yuli Cui
Xueqing Zhu
Hongjun Xu
Linfeng Li
Guangcheng Gao
MicroRNAs: Emerging players in the pathogenesis of vitiligo
Frontiers in Cell and Developmental Biology
MicroRNAs
vitiligo
pathogenesis
miRNA
MiR-25
title MicroRNAs: Emerging players in the pathogenesis of vitiligo
title_full MicroRNAs: Emerging players in the pathogenesis of vitiligo
title_fullStr MicroRNAs: Emerging players in the pathogenesis of vitiligo
title_full_unstemmed MicroRNAs: Emerging players in the pathogenesis of vitiligo
title_short MicroRNAs: Emerging players in the pathogenesis of vitiligo
title_sort micrornas emerging players in the pathogenesis of vitiligo
topic MicroRNAs
vitiligo
pathogenesis
miRNA
MiR-25
url https://www.frontiersin.org/articles/10.3389/fcell.2022.964982/full
work_keys_str_mv AT xinyu micrornasemergingplayersinthepathogenesisofvitiligo
AT yulicui micrornasemergingplayersinthepathogenesisofvitiligo
AT xueqingzhu micrornasemergingplayersinthepathogenesisofvitiligo
AT hongjunxu micrornasemergingplayersinthepathogenesisofvitiligo
AT linfengli micrornasemergingplayersinthepathogenesisofvitiligo
AT guangchenggao micrornasemergingplayersinthepathogenesisofvitiligo